No, Delta-8 THC is not legally permitted in Canada under the Cannabis Act (S.C. 2018, c. 16), as it is classified as a controlled substance unless explicitly authorized by Health Canada. The 2026 compliance framework under the Cannabis Act amendments further tightens restrictions on synthetic cannabinoids, including Delta-8, aligning with international drug control conventions.
Key Regulations for Delta 8 THC in Canada
- Controlled Substance Status: Delta-8 THC is treated as a Schedule II controlled substance under the Controlled Drugs and Substances Act (CDSA), mirroring restrictions on Delta-9 THC. Health Canada’s 2024 Notice to Stakeholders explicitly prohibits its sale, production, or importation without a federal license.
- Licensing Requirements: Only federally licensed cannabis producers (LPs) may manufacture Delta-8 THC, and only if derived from legal cannabis plants (not synthetic pathways). Provincial regulators, such as the Ontario Cannabis Store (OCS), enforce these bans through retail compliance audits.
- 2026 Compliance Deadline: The upcoming Cannabis Act amendments (effective 2026) will criminalize the possession, distribution, or advertisement of Delta-8 THC unless pre-approved under the Industrial Hemp Regulations. Non-compliant products face immediate seizure under the Customs Act.
Health Canada’s Cannabis Tracking System monitors Delta-8 THC as a “restricted cannabinoid,” requiring LPs to report inventory in real-time. Violations trigger penalties under the Cannabis Act, including fines up to CAD $5M or imprisonment.